Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format. Template available in Author Guidelines.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 10-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

ARIS2 Journal - Submission Guidelines

Contents

Any manuscript submitted to ARIS2 must be original and undergo a double-blind review process and plagiarism verification. The manuscript, or substantial parts of it, must not be under consideration by any other journal/publisher with a maximum length of 20 pages.

In any case, where there is the potential for overlap or duplication, transparency from the authors is mandatory. Any potentially overlapping publications should be declared on submission and, where possible, uploaded as additional files with the manuscript. Any overlapping publications should be cited. The Editors of ARIS2 reserve the right to judge potentially overlapping or redundant publications on a case-by-case basis.

Research Format

Most articles published in ARIS2 will be organized into the following sections: title, authors, affiliations, abstract, introduction, methods, results, discussion, references, acknowledgments, figure legends, and table captions. Uniformity in format will help readers and users of the journal. We recognize; however, this format is not ideal for all types of studies. If you have a manuscript that would benefit from a different format, please contact the editors to discuss this further. Although we have no firm length restrictions for the entire manuscript or individual sections, we urge authors to present and discuss their findings concisely, along with maintenance of a logical flow.

Research Title

The title should be specific to the study yet concise and should allow sensitive and specific electronic retrieval of the article. It should be comprehensible to readers outside your field. Avoid specialist abbreviations if possible. Titles should be presented in title case, meaning all words except for prepositions, articles, and conjunctions should be capitalized. If the paper is a randomized controlled trial or a meta-analysis, this description should be in the title. Examples: “Faulty Information Systems Effects on Factories and Dens in the Upper Chao Phraya River and the Lower Ping and Nan Rivers, Thailand”. Please also provide a brief "running head" of approximately 40 characters.

Research Authors and Affiliations

Provide the first names or initials (if used), middle names or initials (if used), surnames, and affiliation details, including department, university or organization, city, state/province (if applicable), and country for all authors. One of the authors should be designated as the corresponding author. It is the corresponding author’s responsibility to ensure that the author list and the summary of the author's contributions to the study are accurate and complete. If the article has been submitted on behalf of a consortium, all consortium members and affiliations should be listed after the Acknowledgments.

Research Abstract

The abstract is divided into the following four sections with these headings: Title, Background, Methods and Findings, and Conclusions. It should contain all the following elements except for items in square brackets, which are only needed for some study types. Please use the same format for abstracts submitted as pre-submission inquiries.

Background: This section should clearly describe the rationale for the study being done. It should end with a statement of the specific study hypotheses and/or study objectives.

Methods and Findings: Describe the participants or what was studied (e.g., cell lines, patient group; be as specific as possible, including numbers studied). Describe the study design/intervention/main methods used/what was primarily being assessed, e.g., primary outcome measure and, if appropriate, over what period. [If appropriate, include how many participants were assessed out of those enrolled, e.g., what was the response rate for a survey.] [If critical to the understanding of the paper, describe how results were analyzed, i.e., which specific statistical tests were used.] For the main outcomes, provide a numerical result if appropriate (it nearly always is) and a measure of its precision (e.g., 95% confidence interval). Describe any adverse events or side effects.
It is always preferable that the authors describe the main limitations of the study.

Conclusions: Provide a general interpretation of the results with any important recommendations for future research. [For a clinical trial, provide any trial identification numbers and names (e.g., trial registration number, protocol number, or acronym).]

Research Introduction

The introduction should discuss the purpose of the study in the broader context. As you compose the introduction, think of readers who are not experts in this field. Include a brief review of the key literature. If there are relevant controversies or disagreements in the field, they should be mentioned so that a non-expert reader can delve into these issues further. The introduction should conclude with a brief statement of the overall aim of the experiments and a comment about whether that aim was achieved.

Research Methods

This section should provide enough detail for the reproduction of the findings. Protocols for new methods should be included, but well-established protocols may simply be referenced. Detailed methodology or supporting information relevant to the methodology can be published on our Web site. This section should also include another section with descriptions of any statistical methods employed. These should conform to the criteria outlined by the Uniform Requirements, as follows: "Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as the use of P values, which fails to convey important quantitative information. Discuss the eligibility of research participants. Give details about randomization. Describe the methods related to the success of any blinding of observations. Authors should report complications of treatment whenever necessary. It is mandatory for the authors to provide a number of observations. Data loss during analysis or observation (such as dropouts from a clinical trial) should be reported by the authors. References for the design of the study and statistical methods should be provided from the standard works when possible (with pages stated) rather than to papers in which the designs or methods were originally reported. Specify any general-use computer programs used."

Research Results

The results section should include all relevant positive and negative findings. The section may be divided into subsections, each with a concise subheading. Large datasets, including raw data, should be submitted as supporting files; these are published online alongside the accepted article. The results section should be written in the past tense. As outlined in the Uniform requirements, authors that present statistical data in the Results section should "...specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Avoid nontechnical uses of technical terms in statistics, such as "random" (which implies a randomizing device), "normal," "significant," "correlations," and "sample." Define statistical terms, abbreviations, and most symbols."

Research Discussion

The discussion should be concise and tightly argued. It should start with a summary of the main findings. It should include paragraphs on the generalizability, clinical relevance, strengths, and, most importantly, the limitations of the study.
You may wish to discuss the following points also. How do the conclusions affect the existing knowledge in the field? How can future research build on these observations? What are the key experiments that must be done?

References

The IEEE Guidelines offer guidance to authors in ARIS2 publication. The permitted style for references is based on the IEEE. 

Acknowledgments

People who contributed to the work but did not fit the criteria for authors should be listed in the Acknowledgments, along with their contributions. You must also ensure that anyone named in the acknowledgments agrees to be so named.
Details of the funding sources that have supported the work should be confined to the funding statement. Do not include them in the Acknowledgments.

Funding

This section should describe sources of funding that have supported the work. Please also describe the role of the study sponsor(s), if any, in study design; collection, analysis, and interpretation of data; writing of the paper; and the decision to submit it for publication.

Competing and conflicting Interests

It is important to consider this carefully. If you don’t declare a conflict of interest and you are subsequently found to have one, your paper will lose credibility. Conversely, full disclosure of conflict of interest does not prevent a paper from being published but does allow you to be open with your readers. This section should list specific competing interests associated with any of the authors. If authors declare that no competing interests exist, we will print a statement to this effect.

Abbreviations

Please keep abbreviations to a minimum. List all non-standard abbreviations in alphabetical order, along with their expanded form. Define them as well upon first use in the text. Non-standard abbreviations should not be used unless they appear at least three times in the text.

Nomenclature

The use of standardized nomenclature in all fields of science and medicine is an essential step toward the integration and linking of scientific information reported in published literature. We will enforce the use of correct and established nomenclature wherever possible: We strongly encourage the use of SI units. If you do not use these exclusively, please provide the SI value in parentheses after each value.

Technologies names should be italicized (e.g., HTML - Hypertext Language Markup ), and the full name must be written out in full, both in the title of the manuscript and at the first mention of a protocol in a paper.

All appropriate datasets, images, and information should be deposited in public resources. Please provide the relevant accession numbers (and version numbers, if appropriate). Accession numbers should be provided in parentheses after the entity on first use.

Figures

If the article is accepted for publication, the author will be asked to supply high-resolution, print-ready versions of the figures. Please ensure that the files conform to our Guidelines for Figure and Table Preparation when preparing your figures for production. After acceptance, authors will also be asked to provide an attractive image to highlight their papers online. Figures may be published under a Creative Commons Attribution License, which allows them to be freely used, distributed, and built upon as long as proper attribution is given. Please do not submit any figures that have been previously copyrighted unless you have express written permission from the copyright holder to publish under the CCAL license.

Figure Legends

The aim of the figure legend should be to describe the key messages of the figure, but the figure should also be discussed in the text. An enlarged version of the figure and its full legend will often be viewed in a separate window online, and it should be possible for a reader to understand the figure without switching back and forth between this window and the relevant parts of the text. Each legend should have a concise title of no more than 15 words. The legend itself should be succinct while still explaining all symbols and abbreviations. Avoid lengthy descriptions of methods.

Tables

All tables should have a concise title. Footnotes can be used to explain abbreviations. Citations should be indicated using the same style as outlined above. Tables occupying more than one printed page should be avoided, if possible. Larger tables can be published as online supporting information. Tables must be cell-based; do not use picture elements, text boxes, tabs, or returns in tables. Please ensure that the files conform to our Guidelines for Figure and Table Preparation when preparing your tables for production.
Requirements for figures and tables

  1. When you submit an article, tables and figures must be submitted as separate files.
  2. Tables must be in Word.doc format.
  3. Line Graphs should be in or .tif or eps formats and have a resolution of 900-1200 dpi. If you are unsure about this, please send us the graph in Microsoft excel format, and we will convert it into eps or .tif formats.
  4. Photographs containing no text must be in jpg or .tif formats with a resolution of 500+ dpi. If you do not have .tif or eps, please submit as jpg.
  5. Images that contain a combination of text and picture elements must be in jpg or .tif or eps formats with a resolution of 500-1200 dpi. If you do not have .tif or eps, please submit it as jpg.
    **** Generally, we will NOT accept any images with resolutions below 300 dpi. You must submit it at least in jpg format; that way, we can change it into any other format accordingly.
    **** Please note that all images must be big (greater than the intended size) and of high resolution.

Submission

Article submissions should be made using the online Editor Manager System or through E-mail IDs provided at the respective journal’s site.

Submitted articles are published immediately after the process of submission, review, and camera ready. All articles are included in Editions, and these are published biannually in a unique volume.

Resubmission

When you have altered your paper in light of the peer reviewer’s comments, and you have written a cover letter to the editor explaining the changes you made or refuting the reviewer’s comments, you are ready to resubmit.
Try to resubmit as soon as you can. Generally, this makes it easier to do as the paper is still fresh in your mind. The scientific world moves quickly, so you want your work published before someone else produces similar work. Once you have resubmitted, you will see the status of the paper changed within a specific span of time. If you don’t see this or don’t receive any acknowledgment of your resubmission, please check with the Editorial staff and confirm the receipt of the article by the Editorial Office.

No Article Processing Charges

ARIS2 is self-financed and does not receive funding from any institution/government. Hence, the Journals operate solely through processing charges we receive from academic/corporate sponsors. Being an Open Access Journal, we do not collect subscription charges from readers and authors, so they enjoy free online publishing/access to their research. 

Articles

Submitted Paper Format (suggested to follow these instructions):

Research paper submissions and Research Papers Publications should follow the journal template (Download ARIS Journal Template). The manuscript should be in English, Times new roman; No Columns.

Manuscript (paper) Structure:

The manuscript should be arranged as follows to be accepted by the Articles Publisher:

1- Title page. 

2- Abstract.

3- Keywords. 

4- Introduction. 

5- Materials and methods. Provide sufficient details of the techniques employed to enable the work to be repeated. Do not describe or refer to commonplace statistical tests in this section but allude to them briefly in Results.

6- Results. State the results and draw attention in the text to important details shown in tables and figures.

7- Discussion. 

8- Citations and references: this journal uses the IEEE Citation Style. (download detailed instructions)

Special Issue

Submitted Paper Format (suggested to follow these instructions):

Research paper submissions and Research Papers Publications should follow the journal template (Download ARIS Journal Template). The manuscript should be in English, Times New Roman; with No Columns.

Manuscript (paper) Structure:

The manuscript should be arranged as follows to be accepted by the Articles Publisher:

1- Title page. 

2- Abstract.

3- Keywords. 

4- Introduction. 

5- Materials and methods. Provide sufficient details of the techniques employed to enable the work to be repeated. Do not describe or refer to commonplace statistical tests in this section but allude to them briefly in Results.

6- Results. State the results and draw attention in the text to important details shown in tables and figures.

7- Discussion. 

8- Citations and references: this journal uses the IEEE Citation Style. (download detailed instructions)

Copyright Notice

ARIS2 - Journal Policies & Copyright

Authors who submit papers with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under an Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
  4. By submitting the processing fee, it is understood that the author has agreed to our terms and conditions which may change from time to time without any notice.
  5. It should be clear for authors that the Editor In Chief is responsible for the final decision about the submitted papers; have the right to accept\reject any paper.  The Editor In Chief will choose any option from the following to review the submitted papers: A. send the paper to two reviewers if the results were negative by one reviewer and positive by the other one; then the editor may send the paper for third reviewer or he takes immediately the final decision by accepting\rejecting the paper. The Editor In Chief will ask the selected reviewers to present the results within 7 working days, if they were unable to complete the review within the agreed period then the editor has the right to resend the papers for new reviewers using the same procedure. If the Editor In Chief was not able to find suitable reviewers for certain papers then he has the right to accept\reject the paper. B. sends the paper to a selected editorial board member(s). C. the Editor In Chief himself evaluates the paper.
  6. The author will take responsibility whatsoever if any copyright infringement or any other violation of any law is done by publishing the research work by the author
  7. Before publishing, the author must check whether this journal is accepted by his employer or any authority he intends to submit his research work. we will not be responsible for this matter.
  8. If at any time, due to any legal reason, if the journal stops accepting manuscripts or could not publish already accepted manuscripts, we will have the right to cancel all or any one of the manuscripts without any compensation or returning back any kind of processing cost.

Competing Interest

  • A competing interest is applicable when the presented information is influenced by the professional or personal association with a person or an organization.
  • The authors need to declare a conflict of interest if any with respect to financial and non-financial (research work) interests.
  • If any competing interest exists with any editor or peer reviewer then they are excluded from handling that manuscript to maintain transparency during the editorial and peer-review process.

Human rights, Animal rights, and Informed Consent

  • This policy has been adopted to publish responsible research findings and to endure that all the necessary approvals and consents have been obtained prior to publication of the outcomes.
  • Authors need to testify that their research has been carried out in accordance with the procedure approved by the respective ethics committees of their organizations. The Editor of the journal takes the final decision on the acceptance and rejection of the manuscript that are subjected scrutiny of issues regarding human and animal ethics.
  • Clinical research/trials involving human data, human specimens, and human subjects must have been performed in accordance with the Helsinki Declaration of the World Medical Association in 1975 as revised in 2008 concerning Human and Animal Rights under the approval of the ethics committee.
  • Justification of the clinical procedure followed may have to be furnished if required by the editor or peer reviewer.
  • Authors are expected to secure informed consent for participation in the study by the human subjects.
  • The experimental procedure and the outcomes involving animal models must comply with the National or International guidelines. The manuscript must include the details (guidelines/permissions/licenses) of such compliance with appropriate references and specifications.

Data sharing

  • Scholarly data includes clinical data, quantitative survey observations, statistical algorithms, transcripts, experimental data, images, videos, audios, etc. The data can be in raw or processed form.
  • The journal encourages sharing of data associated with the research publications for enhancing the chances of accurate reproducibility, better peer-review, better funding opportunity, and citations.
  • The authors are encouraged to share research data in public data repositories under the open access policy and license terms. Accessibility to the shared data may be indicated in the publications in the form of URLs.
  • The data linked to the DOI of the journal enables precise identification and retrieval.

Corrections/Retraction/Withdrawal/Expression of Concern

  • The publisher applies COPE guidelines for the corrections, retractions, withdrawals, and expression of concerns.
  • Errors in publications may necessitate corrections and are given as corrigendum or erratum along with original article citation.
  • Concern regarding the conduct or the integrity of the work or fraudulent presentation is generally taken up with the author's sponsoring organization and the response is conveyed to the Editor-in-Chief for addressing adequately.
  • In order to ensure transparency and integrity of the research communications, this policy is implemented.
  • An article is subjected to retraction under the following conditions: major technical/scientific/experimental error, unrealistic presentations, data fabrication, redundant publication, plagiarism, inappropriate authorship, or unethical research.
  • Editor-in-Chief is the final authority for the retraction of the article. The Editor evaluates the author's response and follows COPE guidelines prior to the retraction.
  • The notice of retraction is posted online in the next issue of the journal.
  • An article can be withdrawn by the corresponding author prior to the acceptance for publication and not after that or peer-review. Withdrawal is permitted if there is conclusive evidence of a violation of ethical code, multiple submissions resulting in the redundant publication of the previous publication elsewhere, authorship claim issues.

Advertising Policy

  • The publisher provides marketing solutions to commercial endeavors to create awareness among the specific targeted audience.
  • The commercially sponsored advertisements are absolutely independent of editorial policy and decisions.
  • The publisher does not endorse any such advertised products.
  • The publisher ensures that the publications are not influenced by commercial interests.
  • The discretion for the selection of advertising content remains with the Publisher.
  • Retention or withdrawal rights of the online advertisements remain with the Editor or the Publisher.
  • Advertisements must comply with the National and International advertising regulation guidelines.

ARIS2 Policy

ARIS2 will support authors by posting the published version of articles to indexation three months after publication.

Editorial Policies and Process

ARIS2 follows a progressive editorial policy that encourages researchers to submit the original research, reviews, and editorial observations as articles, well supported by tables and graphic representation.

All research submitted to ARIS2 will comply with "Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)"

To further questions, please contact: secretariat@aris-journal.com

Copyright Infringement Claims

Notifications regarding any alleged intellectual property infringement should be directed to the editor secretariat@aris-journal.com

Privacy Statement

At ARIS2, we respect your privacy. We want to ensure that you get the information, content, and experiences that matter most to you. ARIS2 is committed to protecting the privacy of its members, customers, volunteers, and other contacts.
This privacy policy applies to all personal data processed by full-time and part-time employees, volunteers when acting on behalf of ARIS2, contractors, and partners doing business on behalf of ARIS2, as well as all legal entities, all operating locations in all countries, and all business processes conducted by ARIS2.

Information collected

What information do we collect?

ARIS2 collects the following personal data in line with the use purposes explained in a subsequent section:

- Your name and contact details
- Date of birth
- Online profile data/usage
- Emergency contact information
- Social media profile information
- Copies of identification documents
- Education and professional information
- Purchasing and payment information
- Registration and participation in ARIS2 events and activities
- Subscription preferences
- Information about the device(s) you use
- Information about service usage
- Cookies
- Authentication data
- Location information
- Author and peer review information
- Other information you upload or provide to us

How do we use your information?

ARIS2 uses (and, where specified, shares) your personal information for the following purposes:

To process transactions. ARIS2 uses personal information such as name, physical address, telephone number, email address, and company/institution to engage in interactions with you, including contacting you about your order, donation, subscription, event participation, or membership. We use financial/credit card and payment information to process your order and may need to share some of this information with delivery services, credit card clearing houses, and other third parties to complete the transaction.

To provide support or other services. ARIS2 may use your personal information to provide you with support or other services that you have ordered or requested. ARIS2 may also use your personal information to respond directly to your requests for information, including registrations for newsletters, webinars, or other specific requests, or pass your contact information to the appropriate ARIS2 distributor or reseller for further follow-up related to your interests.

To provide information based on your needs and respond to your requests. ARIS2 may use your personal information to provide you with notices of new product releases and service developments.

To provide online forums and social networks. Some services available on the websites permit you to participate in interactive discussions, post comments, opportunities, or other content to a bulletin board or exchange, or otherwise engage in networking activities. Some of these services are moderated; all may be accessed for technical reasons (for example, for improvements or fixes). ARIS2 does not control the content that users post to these forums or social networks. You should carefully consider whether you wish to submit personal information to these forums or social networks and tailor any content you submit appropriately and in accordance with the relevant terms of use. You should also review any additional terms and conditions that may govern your use of these services, including terms related to sharing your personal information and receiving communications.

To administer products. ARIS2 may contact you if you purchase products to confirm certain information about your order (for example, that you did not experience problems in the download process). We may also use this information to confirm compliance with licensing and other terms of use, and may share it with your company/institution.

To select content, improve quality, and facilitate the use of the websites. ARIS2 may use your personal information, including the information gathered as a result of site navigation and electronic protocols and cookies (including third-party cookies), to help create and personalize website content, improve website quality, track marketing campaign responsiveness, evaluate page response rates, conduct usability testing, and facilitate your use of the websites (for example, to facilitate navigation and the login process, avoid duplicate data entry, enhance security, keep track of shopping cart additions, and preserve order information between sessions).

To serve personalized advertising to you. We don't share your information with advertisers without your consent. We allow advertisers to choose the characteristics of Users who will see their advertisements, and we may use any of the non-personally identifiable attributes we have collected to select the appropriate audience for those advertisements. When you click on or otherwise interact with an advertisement, there is a possibility that the advertiser may place a cookie in your browser, and that your attributes meet the criteria the advertiser selected.

To assess the usage of ARIS2 products and services. ARIS2 may track your usage of ARIS2 products and services (e.g., ARIS2 Membership) to determine your usage level, and those usage statistics may be made available to ARIS2 content licensors and your company/institution.

To communicate with you about a meeting, conference, or event. We may communicate with you about a meeting, conference, or event hosted or co-sponsored by ARIS2 or one of our business associates. This may include information about the event's content, event logistics, payment, updates, and additional information related to the event. Information you provide when registering for or participating in a conference managed or co-sponsored by parties other than or in addition to ARIS2 may be shared with those parties, and the treatment of such information is further subject to the privacy policies of those parties. ARIS2 and its conference co-sponsors may contact you after the event about the event, subsequent iterations of the event, and related events. Please note that ARIS2 conference, meeting, or event organizers, co-sponsors, exhibitors, and other third parties may directly request your personal information at their conference booths or presentations. Providing your information to them is optional, and you should review their privacy policies to address your particular needs and concerns about how they will treat your personal information.

To consider you for a higher member grade or an ARIS2 award. ARIS2 may use personal information such as your name, education, work history, and volunteer activities to consider you for a higher member grade or for an ARIS2 award. ARIS2 may need to share this information with your nominators, references, judges, and other parties involved in evaluating your eligibility.

To document standards development participation. If you are a participant in ARIS2 standards development, ARIS2 uses your personal information to comply with policies and procedures, legal and accreditation requirements, and evaluation of patent claims by patent offices. ARIS2 must capture your personal data for these purposes and provide information about activities related to standards development groups in which you participate. ARIS2 standards development participation is documented through various methods, e.g., rosters, submission documents, email reflectors, records of meeting attendance, responses to ballots, publicly available participation lists, and declaration of affiliations.

To assist in your participation in ARIS2 activities. ARIS2 will communicate with you if you are participating in certain ARIS2 activities, such as ARIS2 conferences, authoring or reviewing an ARIS2 periodical article, or ARIS2 humanitarian activities. ARIS2 may send you information, such as newsletters related to those activities.

To update you on relevant ARIS2 benefits, programs, and opportunities. ARIS2 may communicate with you regarding relevant ARIS2 benefits, programs, and opportunities available to you through your membership(s) with ARIS2.

To engage with third parties. ARIS2 may share your personal data with third parties in connection with services that these individuals or entities perform for or with ARIS2. These third parties are restricted from using this data in any way other than to provide services for ARIS2 or for the collaboration in which they and ARIS2 are contractually engaged (for example, hosting an ARIS2 database or engaging in data processing on ARIS2 behalf or mailing you information that you requested). These third parties are carefully selected by ARIS2 and are obligated to keep your data secure. From time to time, we may also share your information with third parties who we think might provide content, products, or services of interest to you.

To protect ARIS2 content and services. We may use your information to prevent potentially illegal activities and to enforce our terms and conditions. We also use a variety of technological systems to detect and address anomalous activity and to screen content to prevent abuse, such as spam. These efforts may, on occasion, result in a temporary or permanent suspension or termination of some functions for some users.

To get feedback or input from you. In order to deliver products and services of most interest to our customers, from time to time, we may ask members, customers, volunteers, and website visitors to provide us input and feedback (for example, through surveys, usability studies, and focus groups).

To protect ARIS2 information assets as well as your own personal data. The ARIS2 Information Security Program protects the confidentiality, integrity, and availability of ARIS2 information assets by following a risk management approach based on policies, standards, guidelines, and procedures to meet security objectives while supporting business and operational goals.

How can you control your information?

You can control the information we have about you and how we use it in several ways.

  • If you are a registered user, you can review, revise, and correct the personal data that you have provided to ARIS2 via MyProfile. 
  • Use the unsubscribe method provided in our various communications

Personal data about minors and children

ARIS2 does not knowingly collect data from or about children under 16 without the permission of the parent(s)/guardian(s). If we learn that we have collected personal information from a child under 16, we will delete that information as quickly as possible. If you believe that we might have any information from or about a child under age 16, please contact us.

How will you know if the Privacy Policy is changed? 

ARIS2 may update its Privacy Policy from time to time. If we make any material changes, we will notify you by email if you have an ARIS2 Account or by means of a notice on this website prior to the change becoming effective. We encourage you to periodically review this page for the latest information on our privacy practices.

Technical and regulatory information

Logging practices

ARIS2 automatically records the Internet Protocol (IP) addresses of visitors. The IP address is a unique number assigned to every computer on the Internet. Generally, an IP address changes each time you connect to the internet (it is a "dynamic" address). Note, however, that if you have a broadband connection, depending on your individual circumstances, the IP address that we collect may contain information that could be deemed identifiable. This is because, with some broadband connections, your IP address doesn't change (it is "static") and could be associated with your personal computer.

As well as recording the IP addresses of users, ARIS2 may also keep track of sites that users visited immediately prior to visiting the ARIS2 website and the search terms they used to find them. We keep track of the pages visited on the ARIS2 website, the amount of time spent on those pages, and the types of searches done on them. Your searches remain confidential and anonymous. ARIS2 uses this information only for statistical purposes to find out which pages users find most useful and to improve the website.

ARIS2 also captures and stores information that you transmit. This may include:

  • Browser/Device type/version
  • Operating system used
  • Media Access Control (MAC) address
  • Date and time of the server request
  • The volume of data transferred

External links behavior

Some ARIS2 websites link to other sites created and maintained by other public- and/or private-sector organizations. ARIS2 provides these links solely for your information and convenience. When you transfer to an outside website, you are leaving the ARIS2 domain, and ARIS2 information management policies no longer apply. ARIS2 encourages you to read the privacy statement of each external website that you visit before you provide any personal data.

Cookies and web beacons

Cookies and web beacons are electronic placeholders that are placed on your device by websites to track your individual movements on that website over time. ARIS2 uses both session-based cookies (which last only for the duration of the user's session) and persistent cookies (which remain on your device and provide information about the session you are in and wait for the next time you use that site again). 

These cookies and web beacons provide useful information to ARIS2, enabling us to recognize repeat users, facilitate the user's access to and use of our sites, allow us to track usage behavior, and balance the usage of our websites on all ARIS2 web servers. 

Tracking cookies, third-party cookies, and other technologies such as web beacons may be used to process additional information, enable non-core functionalities on the ARIS2 website, and enable third-party functions (such as a social media "share" link). We may also include web beacons and other similar technology in promotional email messages to determine whether the messages have been opened. 

Do Not Track (DNT)

The online advertising industry has self-regulatory initiatives designed to provide consumers a choice in the types of ads they may see online and to conveniently opt-out from online behavioral ads served by some or all of the companies participating in these programs. Our websites do not respond to DNT consumer browser settings.

Collaboration with authorities

ARIS2 has appointed and mandated a Data Protection Officer by NRMC.PT represents the regulatory authorities inside the ARIS2 Journal and in return, represents the ARIS2 organization to regulatory authorities.

The ARIS2 Data Protection Officer will ensure proper communication with the relevant regulatory authority for privacy. The privacy officer will lead investigative action, complaint handling, and data breach notification. The privacy officer will also monitor regulatory changes and consult the regulatory authority where the implementation of a regulatory or technological change leads to doubt. 

Transfer of information to other countries 

As a global organization, ARIS2 engages in a number of international activities.  In connection with the management of those activities, ARIS2 may transfer information to other countries. By submitting your information to ARIS2 via the websites, or in connection with your interactions with ARIS2 offline, you consent to such transfers and to the processing of this information in other countries.

Responses to legal requests

ARIS2 reserves the right to share your information to respond to duly authorized information requests of governmental authorities or where required by law. 

In the event of bankruptcy, merger, acquisition, reorganization, or sale of assets, your information may be sold or transferred as part of that transaction. The promises in this privacy policy will apply to your information as transferred to the new entity.

Your data rights

ARIS2 complies with all applicable data privacy laws and regulations, including, but not limited to, the General Data Protection Regulation (GDPR) and the California Consumer Privacy Act (CCPA). Under these laws and regulations, you may have certain rights to your data. Should you wish to exercise any of these rights, please send an email request to dpo@nrmc.pt with "Data Privacy Request" in the subject line, and in the email, please identify the specific privacy right you request assistance with. Please note that additional information may be requested prior to fulfilling a request, and that ARIS2 reserves the right to charge a fee, where permitted, to cover the cost of certain requests. 

How do I contact you if there is an issue?

If you have any questions or concerns about this Privacy Policy or about the use of your personal information, please feel free to contact us by email at dpo@nrmc.pt. 

Date
12 May 2025 
Version 1.4